+Compare
TRIB
Stock ticker:
NASDAQ
AS OF
Jul 1 closing price
Price
$1.32
Change
+$0.09 (+7.32%)
Capitalization
46.68M

TRIB Price Prediction, Trinity Biotech plc AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jul 01, 2022

Aroon Indicator for TRIB shows an upward move is likely

TRIB's Aroon Indicator triggered a bullish signal on June 15, 2022. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 125 similar instances where the Aroon Indicator showed a similar pattern. In 107 of the 125 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 01, 2022. You may want to consider a long position or call options on TRIB as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

TRIB moved above its 50-day moving average on July 01, 2022 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TRIB advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

TRIB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for TRIB moved out of overbought territory on June 06, 2022. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 40 cases where TRIB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TRIB turned negative on June 29, 2022. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRIB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TRIB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (26.810) is normal, around the industry mean (7.206). P/E Ratio (33.003) is within average values for comparable stocks, (91.710). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.169). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (0.378) is also within normal values, averaging (89.430).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRIB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

TRIB is expected to report earnings to fall 87.21% to 0 cents per share on July 21

Trinity Biotech plc TRIB Stock Earnings Reports
Q2'22
Est.
$-0.01
Q1'22
Missed
by $0.04
Q4'21
Missed
by $0.01
Q3'21
Missed
by $0.03
Q2'21
Beat
by $0.14
The last earnings report on June 30 showed earnings per share of -7 cents, missing the estimate of -3 cents. With 37.65K shares outstanding, the current market capitalization sits at 46.68M.
AI
A.I.Advisor
published Dividends

TRIB paid dividends on July 01, 2015

Trinity Biotech plc TRIB Stock Dividends
А annual dividend of $0.05 per share was paid with a record date of July 01, 2015, and an ex-dividend date of June 05, 2015. Read more...
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Edwards Lifesciences Corp (NYSE:EW), Boston Scientific Corp (NYSE:BSX), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 5.66B. The market cap for tickers in the group ranges from 775 to 3.72T. MKYSF holds the highest valuation in this group at 3.72T. The lowest valued company is BIIO at 775.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -1%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -26%. HTGM experienced the highest price growth at 98%, while ABMT experienced the biggest fall at -77%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -84%. For the same stocks of the Industry, the average monthly volume growth was -67% and the average quarterly volume growth was -66%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 60
SMR Rating: 67
Profit Risk Rating: 84
Seasonality Score: -2 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a devloper of medical diagnostic products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
IDA Business Park
Phone
+353 12769800
Employees
477
Web
https://www.trinitybiotech.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FGEN11.400.84
+7.95%
FibroGen
CGTX2.250.14
+6.64%
Cognition Therapeutics
OLLI61.332.58
+4.39%
Ollie's Bargain Outlet Holdings
ITUB4.26-0.03
-0.58%
Itau Unibanco Holding SA
USAK31.05-0.37
-1.18%
USA Truck

TRIB and

Correlation & Price change

A.I.dvisor tells us that TRIB and BNGO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRIB and BNGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRIB
1D Price
Change %
TRIB100%
+7.76%
BNGO - TRIB
31%
Poorly correlated
-2.90%
MLSS - TRIB
30%
Poorly correlated
+11.41%
NVRO - TRIB
30%
Poorly correlated
+4.04%
DMTK - TRIB
29%
Poorly correlated
-0.36%
ESTA - TRIB
29%
Poorly correlated
+1.08%
More